Tiffanee Padgett
Nurse Practitioner · Perry, FLNPI 1558307421
Payments from drug & device makers
Across 107 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$248
- Merck$208
- Novartis$195
- AbbVie$159
- Amgen$151
- GSK$138
- plus $681 from 17 others
What the payments were for
- Food & beverage$1,780100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 17 | $248 |
| Merck | 12 | $208 |
| Novartis | 10 | $195 |
| AbbVie | 11 | $159 |
| Amgen | 9 | $151 |
| GSK | 9 | $138 |
| Novo Nordisk | 6 | $103 |
| Pharming Healthcare, Inc. | 3 | $84 |
| Lilly USA, LLC | 4 | $76 |
| Exact Sciences | 3 | $55 |
| AstraZeneca | 4 | $55 |
| Bayer | 3 | $54 |
| Biogen | 3 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Dexcom, Inc. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Boehringer Ingelheim | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$1,780 in reported general payments places this provider in the 80th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 81 | $87,421 |
| MounjaroTirzepatide | 60 | $60,797 |
| EliquisApixaban | 33 | $50,732 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $46,800 |
| FarxigaDapagliflozin Propanediol | 48 | $45,103 |
| JardianceEmpagliflozin | 25 | $36,030 |
| JanuviaSitagliptin Phosphate | 20 | $26,264 |
| Repatha SureclickEvolocumab | 26 | $20,075 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $5,213 |
| Omeprazole | 198 | $3,830 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 95 | $3,500 |
| Atorvastatin Calcium | 424 | $3,415 |
| SynthroidLevothyroxine Sodium | 35 | $2,710 |
| Gabapentin | 123 | $2,598 |
| Esomeprazole Magnesium | 39 | $2,476 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $103 | $87,42181 claims |
| Lilly USA, LLCMounjaro | $76 | $60,79760 claims |
| PfizerEliquis, Paxlovid | $248 | $52,16149 claims |
| GSKTrelegy Ellipta | $138 | $46,80034 claims |
| AstraZenecaFarxiga | $55 | $45,10348 claims |
| Boehringer IngelheimJardiance | $12 | $36,03025 claims |
| MerckJanuvia | $208 | $26,26420 claims |
| AbbVieSynthroid | $159 | $2,71035 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Perry
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.